Clinical Glomerulonephritis 4

15 Apr 2024 5:45 p.m. 6:45 p.m.

MON-089 to MON-114

Ana Malvar Poster Moderator

Time	Session

5:45 p.m. 6:45 p.m.	ORIGIN 3: PIVOTAL PHASE 3 STUDY EVALUATING EFFECT OF ATACICEPT VS PLACEBO ON PROTEINURIA AND RENAL FUNCTION PRESERVATION IN IGA NEPHROPATHY WCN24-AB-1414, Poster Board= MON-089 MON-089 Jonathan Barratt Poster Presenter	IMAGINATION: A GLOBAL PHASE 3 TRIAL OF RO7434656, AN ANTISENSE OLIGONUCLEOTIDE INHIBITOR OF COMPLEMENT FACTOR B, IN IGA NEPHROPATHY WCN24-AB-912, Poster Board= MON-090 MON-090 Jonathan Barratt Poster Presenter	ATACICEPT IN IGA NEPHROPATHY: CONTINUED PROTECTIVE TITERS TO DIPHTHERIA AND TETANUS AND BALANCED INFECTIONS VS PLACEBO WITH A FOCUS ON COVID-19 WCN24-AB-342, Poster Board= MON-091 MON-091 Jonathan Barratt Poster Presenter	MORTALITY FROM GLOMERULAR DISEASES IN BRAZIL: AN EPIDEMIOLOGICAL ANALYSIS FROM 2011 TO 2021 WCN24-AB-2367, Poster Board= MON-092 MON-092 Geraldo Bezerra Da Silva Junior Poster Presenter	OPTIMIZING RENAL BIOPSY SAFETY: A PROTOCOL ADDRESSING BLEEDING RISK FACTORS WITH LOW COMPLICATION RATES WCN24-AB-1444, Poster Board= MON-093 MON-093 Valeria Brozzi Poster Presenter	ANALYSIS OF CLINICOPATHOLOGICAL CHARACTERISTICS OF MEMBRANOUS NEPHROPATHY WITH CONCOMITANT MALIGNANCY AND LITERATURE REVIEW WCN24-AB-2320, Poster Board= MON-094 MON-094 Hong Cheng Poster Presenter	Worldwide Use of Sodium Glucose Co-transporter 2 Inhibitors in Immunoglobulin A nephropathy: A country and Regional Analysis WCN24-AB-1354, Poster Board= MON-095 MON-095 Chee Kay Cheung Poster Presenter	ASSOCIATION OF THE POLYMORPHISMS OF THE ANGIOTENSIN-CONVERTING ENZYME GENES AND FRMD3 IN THE DEVELOPMENT OF DIABETIC KIDNEY DISEASE IN THE MEXICAN POPULATION. WCN24-AB-312, Poster Board= MON-096 MON-096 Juan Daniel Diaz Garcia Poster Presenter	EFFECTS OF DAPAGLIFLOZIN IN PATIENTS WITH MEMBRANOUS NEPHROPATHY WCN24-AB-1766, Poster Board= MON-097 MON-097 Hiddo Lambers Heerspink Poster Presenter	KIDNEY RE-BIOPSY IN ADULTS WITH IGA NEPHROPATHY WCN24-AB-2606, Poster Board= MON-098 MON-098 Leonel Langellotti Poster Presenter	BIOPSY-PROVEN KIDNEY DISEASES IN THE ELDERLY: A STUDY IN MEXICAN POPULATION WCN24-AB-1463, Poster Board= MON-099 MON-099 Jessica Lázaro Poster Presenter	BI-FUNCTIONAL C5 ANTIBODY-FUSION PROTEIN (LP-005) WITH POTENTIAL BEST-IN-CLASS BIOACTIVITY FOR COMPLEMENT INHIBITION WCN24-AB-2025, Poster Board= MON-100 MON-100 Heng Liu Poster Presenter	JAK/STAT EXPRESSION IN PATIENTS WITH IGA NEPHROPATHY WCN24-AB-186, Poster Board= MON-101 MON-101 Mateus Luvizotto Poster Presenter	NATURAL HISTORY OF PRIMARY MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS: HOW DOES 1-YEAR PROTEINURIA CORRELATE WITH LONG-TERM RENAL OUTCOME? WCN24-AB-2379, Poster Board= MON-102 MON-102 Maddalena Marasa Poster Presenter	RESPONSE TO TREATMENT IN MEN WITH LUPUS NEPHRITIS: A STUDY IN MEXICAN POPULATION WCN24-AB-1468, Poster Board= MON-103 MON-103 Margarita Marlene Padilla Morales Poster Presenter	OUTCOMES OF ATYPICAL HEMOLYTIC UREMIC SYNDROME WCN24-AB-1000, Poster Board= MON-104 MON-104 Narayan Prasad Poster Presenter	CLINICAL CHARACTERISTICS OF PATIENTS WITH C3 GLOMERULOPATHY AND IDIOPATHIC MEMBRANOPROLIFERATIVE IMMUNE COMPLEX GLOMERULONEPHRITIS IN A HOSPITAL IN ARGENTINA WCN24-AB-2435, Poster Board= MON-105 MON-105 Lucas Raul Ramos Poster Presenter	Towards an IgA Nephropathy Atlas WCN24-AB-1863, Poster Board= MON-106 MON-106 Julio Saez-Rodriguez Poster Presenter	HISTOPATHOLOGICAL FINDINGS IN THE RENAL BIOPSY OF NATIVE KIDNEYS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2-DM) WCN24-AB-685, Poster Board= MON-107 MON-107 Ricardo Silvariño Poster Presenter	End-Stage Kidney Disease (ESKD) and Chronic Kidney Disease (CKD) Progression among a Hispanic/Latino Population with Primary Immunoglobulin A Nephropathy (IgAN) WCN24-AB-1268, Poster Board= MON-108 MON-108 John Sim Poster Presenter	COMPARATIVE ANALYSIS OF INTERNATIONAL IGAN PREDICTION TOOL SCORES DURING TIME OF BIOPSY AND ONE-YEAR POST-BIOPSY IN PREDICTING RENAL OUTCOMES AMONG FILIPINO PATIENTS WITH IGA NEPHROPATHY WCN24-AB-2046, Poster Board= MON-109 MON-109 Jan Joel Simpauco Poster Presenter	BEYOND: A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF ZIGAKIBART IN ADULTS WITH IGA NEPHROPATHY WCN24-AB-1837, Poster Board= MON-110 MON-110 Hernan Trimarchi Poster Presenter	SAFETY AND EFFICACY OF ANIFROLUMAB IN IMMUNE COMPLEX AND APOL-1 ASSOCIATED LUPUS PODOCYTOPATHY WCN24-AB-420, Poster Board= MON-111 MON-111 James Tumlin Poster Presenter	A TEN-YEAR EXPERIENCE OF ATYPICAL HEMOLYTIC UREMIC SYNDROME: A MONOCENTRIC PROSPECTIVE EXPERIENCE. WCN24-AB-1780, Poster Board= MON-112 MON-112 Mariana Ursino Poster Presenter	IL-1? and NLRP3 gene expression profile with dapagliflozin in inactive Lupus Nephritis WCN24-AB-1358, Poster Board= MON-113 MON-113 Gisele Vajgel Fernandes Poster Presenter	Treatment decision-making modle for IgA nephropathy: a real-world study WCN24-AB-733, Poster Board= MON-114 MON-114 Ying Zheng Poster Presenter